Prostatis Group’s InMode INMD Stock Holding History

Prostatis Group’s Portfolio INMD Stock Details INMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,692	Closed	-$320K	–	81
2020 Q3	$320K	Buy	+17,692	New	+$290K	0.3%	63

Other funds holding INMD

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MGM

Miura Global Management New York $43.8M AUM 53.8% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prostatis Group's INMD Position: Q4 2020 in Review

Prostatis Group sold out of InMode (INMD) in Q4 2020, closing a stake of 17,692 shares — an estimated $320K sold.

Prostatis Group first reported a position in INMD in Q3 2020 and held it in 1 quarter. The position peaked at $320K in Q3 2020. 180 funds tracked by Wall St. Rank hold INMD as of Q4 2020.

Prostatis Group reported no remaining InMode position as of Q4 2020 after selling out during the quarter.
Prostatis Group sold 17,692 InMode shares in Q4 2020, an estimated $320K.
Prostatis Group first reported a position in InMode in Q3 2020 and held it in 1 quarter.
Prostatis Group's InMode position peaked at $320K in Q3 2020.
180 funds tracked by Wall St. Rank held InMode as of Q4 2020.

Based on Prostatis Group's 13F filing for Q4 2020, filed 23 Mar 2023.